- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | 6.77% | 29,177,964 | $868,627,988 | 244,593 | 0.85% | Form 4 | |
| TYRA | TYRA BIOSCIENCES, INC. | 3.13% | 14,130,492 | $359,338,412 | 1,931,867 | 15.84% | 13D | |
| CLYM | Climb Bio, Inc. | 2.35% | 23,249,186 | $299,914,499 | 11,948,247 | 105.73% | 13D | |
| ARTV | Artiva Biotherapeutics, Inc. | 1.44% | 18,489,293 | $183,598,679 | 533,651 | 2.97% | Form 4 | |
| SLDB | SOLID BIOSCIENCES INC | 0.93% | 12,036,126 | $120,240,899 | 2,696,148 | 28.87% | $9.99 | 13F |
| ZLAB | ZAI LAB LTD-ADR | 0.85% | 5,743,533 | $109,127,127 | 36,271 | 0.64% | $19 | 13F |
| VOR | Vor Biopharma Inc. | 0.69% | 4,501,882 | $88,912,170 | 2,099,787 | 87.41% | Form 4 | |
| XNCR | XENCOR INC | 0.66% | 5,274,274 | $84,915,811 | 377,037 | 7.7% | $16.1 | 13F |
| ACRS | ACLARIS THERAPEUTICS INC | 0.52% | 12,723,026 | $67,304,808 | 5,918,954 | 86.99% | $5.29 | 13F |
| DMRA | DAMORA THERAPEUTICS INC | 0.49% | 2,399,702 | $62,416,249 | 392 | 0.02% | $26.01 | 13F |
| RZLT | REZOLUTE INC | 0.38% | 9,445,039 | $49,114,203 | 265,039 | 2.89% | $5.2 | 13F |
| BIOA | BIOAGE LABS INC | 0.32% | 1,671,648 | $40,972,092 | 21,000 | 1.27% | $24.51 | 13F |
| SABS | SAB Biotherapeutics, Inc. | 0.31% | 9,609,852 | $36,997,930 | 5,208,352 | 118.33% | 13D | |
| ACRV | ACRIVON THERAPEUTICS INC | 0.17% | 12,229,396 | $21,768,325 | 3,888,888 | 46.63% | $1.78 | 13F |
| CAPR | Capricor Therapeutics, Inc. | 0.17% | 3,014,183 | $21,099,281 | 1,506,339 | 99.90% | 13G | |
| AVTX | AVALO THERAPEUTICS INC | 0.14% | 1,000,000 | $18,480,000 | 337,032 | 50.84% | $18.48 | 13F |